InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by GRAINGER DAVID J, Responsable de l'Innovation. Officer active across 1 companies, notably Centessa Pharmaceuticals plc. In total, 2 disclosures have been published. Total volume traded: €446k. The latest transaction was filed on 28 January 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€223,15727,500 shares@ €8.11480.0036% mcap100.0% of flow
Ordinary Shares
SEC:0000899243-22-003924·
Ideal exit: 25 Oct 2022 (T+270)
€223,15727,500 shares@ €8.11480.0036% mcap50.0% of flow
Ordinary Shares
SEC:0000899243-22-003924:0·
Ideal exit: 25 Oct 2022 (T+270)
2 of 2 declarations
About GRAINGER DAVID J
David J. Grainger is the Chief Innovation Officer at Centessa Pharmaceuticals plc. He is responsible for leading innovation and research initiatives within the company. His role involves identifying new opportunities and developing innovative solutions to enhance Centessa's products and services.
